Cardinal Health (CAH) to Release Earnings on Friday

Cardinal Health (NYSE:CAH) is scheduled to announce its earnings results before the market opens on Friday, November 1st. Analysts expect the company to announce earnings of $1.64 per share for the quarter. Cardinal Health has set its FY 2025 guidance at 7.550-7.700 EPS and its FY25 guidance at $7.55-7.70 EPS.Parties that wish to register for the company’s conference call can do so using this link.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Wednesday, August 14th. The company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.10. Cardinal Health had a net margin of 0.37% and a negative return on equity of 54.85%. The firm had revenue of $59.87 billion for the quarter, compared to the consensus estimate of $58.74 billion. During the same quarter in the prior year, the company posted $1.55 earnings per share. The company’s revenue for the quarter was up 12.1% compared to the same quarter last year. On average, analysts expect Cardinal Health to post $8 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Cardinal Health Trading Up 0.2 %

NYSE:CAH opened at $112.15 on Friday. The company has a market capitalization of $27.32 billion, a P/E ratio of 49.84, a PEG ratio of 1.57 and a beta of 0.60. The firm has a fifty day simple moving average of $111.62 and a 200-day simple moving average of $104.05. Cardinal Health has a 12 month low of $90.19 and a 12 month high of $116.05.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st were issued a dividend of $0.506 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend was Tuesday, October 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is 89.78%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CAH. Evercore ISI lifted their price target on shares of Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a research note on Thursday, August 15th. UBS Group boosted their price objective on Cardinal Health from $125.00 to $134.00 and gave the stock a “buy” rating in a research note on Tuesday. StockNews.com raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Thursday, October 17th. Argus increased their price target on Cardinal Health from $115.00 to $125.00 and gave the stock a “buy” rating in a report on Wednesday, September 11th. Finally, Morgan Stanley increased their price objective on shares of Cardinal Health from $114.00 to $119.00 and gave the stock an “overweight” rating in a research report on Thursday, August 15th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $120.18.

Insider Activity

In other news, insider Jessica L. Mayer sold 16,573 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $109.39, for a total transaction of $1,812,920.47. Following the transaction, the insider now directly owns 75,971 shares in the company, valued at approximately $8,310,467.69. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, insider Jessica L. Mayer sold 16,573 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $109.39, for a total transaction of $1,812,920.47. Following the completion of the sale, the insider now owns 75,971 shares in the company, valued at approximately $8,310,467.69. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Aaron E. Alt sold 2,323 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $108.91, for a total value of $252,997.93. Following the completion of the transaction, the chief financial officer now owns 36,867 shares in the company, valued at $4,015,184.97. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 113,963 shares of company stock valued at $12,379,980. Insiders own 0.15% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.